Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125477931 | 12547793 | 1 | I | 20160628 | 20160712 | 20160712 | EXP | US-MACLEODS PHARMACEUTICALS US LTD-MAC2016002886 | MACLEODS | 0.00 | Y | 0.00000 | 20160712 | OT | GB | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125477931 | 12547793 | 1 | PS | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Unknown | 750 MG, QD | N | U | 0 | 750 | MG | ||||||
| 125477931 | 12547793 | 2 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Unknown | 30 MG, QD | U | 0 | 30 | MG | |||||||
| 125477931 | 12547793 | 3 | C | CETIRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | Endocervical | 10 MG, QD | U | 0 | 10 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125477931 | 12547793 | 1 | Epididymitis |
| 125477931 | 12547793 | 2 | Product used for unknown indication |
| 125477931 | 12547793 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125477931 | 12547793 | DS |
| 125477931 | 12547793 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125477931 | 12547793 | Affective disorder | |
| 125477931 | 12547793 | Anxiety | |
| 125477931 | 12547793 | Arthralgia | |
| 125477931 | 12547793 | Atrophy | |
| 125477931 | 12547793 | Autonomic nervous system imbalance | |
| 125477931 | 12547793 | Bradycardia | |
| 125477931 | 12547793 | Cognitive disorder | |
| 125477931 | 12547793 | Depression | |
| 125477931 | 12547793 | Eye disorder | |
| 125477931 | 12547793 | Fatigue | |
| 125477931 | 12547793 | Fibromyalgia | |
| 125477931 | 12547793 | Gait disturbance | |
| 125477931 | 12547793 | Gastrointestinal disorder | |
| 125477931 | 12547793 | Gastrointestinal motility disorder | |
| 125477931 | 12547793 | Muscular weakness | |
| 125477931 | 12547793 | Myalgia | |
| 125477931 | 12547793 | Polyneuropathy | |
| 125477931 | 12547793 | Respiratory muscle weakness | |
| 125477931 | 12547793 | Tachycardia | |
| 125477931 | 12547793 | Tendon disorder | |
| 125477931 | 12547793 | Tendon pain | |
| 125477931 | 12547793 | Toxicity to various agents | |
| 125477931 | 12547793 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |